Literature DB >> 3042436

Serological tests in leprosy. The sensitivity, specificity and predictive value of ELISA tests based on phenolic glycolipid antigens, and the implications for their use in epidemiological studies.

P J Burgess1, P E Fine, J M Ponnighaus, C Draper.   

Abstract

This paper examines the sensitivity and specificity of two ELISA assays for IgM antibodies to Mycobacterium leprae, one employing natural phenolic glycolipid and the other employing a synthetic disaccharide glycoconjugate as antigen. Estimates of sensitivity and specificity are derived, based on a panel of sera from leprosy cases in Malawi and various non-leprosy controls from the UK. Though both assays were able to identify a high proportion of multibacillary patients, neither was able to detect a high proportion of paucibacillary patients without considerable loss of specificity. The implications of the inverse relationship between sensitivity and specificity are discussed with reference to the predictive value of such tests in such areas as Malawi, where the large majority of cases are paucibacillary.

Entities:  

Mesh:

Year:  1988        PMID: 3042436      PMCID: PMC2249338          DOI: 10.1017/s0950268800029320

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   2.451


  15 in total

1.  Bias due to misclassification in the estimation of relative risk.

Authors:  K T Copeland; H Checkoway; A J McMichael; R H Holbrook
Journal:  Am J Epidemiol       Date:  1977-05       Impact factor: 4.897

2.  The Lepra Evaluation Project (LEP), an epidemiological study of leprosy in Northern Malaŵi. I. Methods.

Authors:  J M Ponninghaus; P E Fine; L Bliss; I J Sliney; D J Bradley; R J Rees
Journal:  Lepr Rev       Date:  1987-12       Impact factor: 0.537

Review 3.  Leprosy: the epidemiology of a slow bacterium.

Authors:  P E Fine
Journal:  Epidemiol Rev       Date:  1982       Impact factor: 6.222

4.  Antibodies to phenolic glycolipid-1 and to whole Mycobacterium leprae in leprosy patients: evolution during therapy.

Authors:  M A Bach; D Wallach; B Flageul; A Hoffenbach; F Cottenot
Journal:  Int J Lepr Other Mycobact Dis       Date:  1986-06

5.  Isolation of the Mycobacterium leprae-specific glycolipid antigen, phenolic glycolipid-I, from formalin-fixed human lepromatous liver.

Authors:  S Izumi; K Sugiyama; T Fujiwara; S W Hunter; P J Brennan
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

6.  Quantitation of the phenolic glycolipid of Mycobacterium leprae and relevance to glycolipid antigenemia in leprosy.

Authors:  S N Cho; S W Hunter; R H Gelber; T H Rea; P J Brennan
Journal:  J Infect Dis       Date:  1986-03       Impact factor: 5.226

7.  Serological specificity of phenolic glycolipid I from Mycobacterium leprae and use in serodiagnosis of leprosy.

Authors:  S N Cho; D L Yanagihara; S W Hunter; R H Gelber; P J Brennan
Journal:  Infect Immun       Date:  1983-09       Impact factor: 3.441

8.  Serological activity of a characteristic phenolic glycolipid from Mycobacterium leprae in sera from patients with leprosy and tuberculosis.

Authors:  S J Brett; P Draper; S N Payne; R J Rees
Journal:  Clin Exp Immunol       Date:  1983-05       Impact factor: 4.330

9.  Use of synthetic glycoconjugates containing the Mycobacterium leprae specific and immunodominant epitope of phenolic glycolipid I in the serology of leprosy.

Authors:  S J Brett; S N Payne; J Gigg; P Burgess; R Gigg
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

10.  Use of an artificial antigen containing the 3,6-di-O-methyl-beta-D-glucopyranosyl epitope for the serodiagnosis of leprosy.

Authors:  S N Cho; T Fujiwara; S W Hunter; T H Rea; R H Gelber; P J Brennan
Journal:  J Infect Dis       Date:  1984-09       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.